By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Feinstein Kean Healthcare, Inc. 

245 First Street, 14th Floor

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-577-8110 Fax: 617-577-8985



Company News
Feinstein Kean Healthcare, Inc. Release: Robert Finn Named Executive Editor of Multiple Sclerosis Discovery Forum for ACP 7/9/2013 6:38:37 AM
Alfacell (ACEL) Selects TS Communications And Feinstein Kean Healthcare, Inc. For Comprehensive Integrated Communications 9/18/2006 12:18:43 PM
Janssen Pharmaceutica Products, L.P. And Feinstein Kean Healthcare Release: RISPERDAL (risperidone) Shown To Rapidly Reduce Manic Symptoms Associated With Bipolar Disorder10/19/2005 5:11:35 PM
ANZACC: Scientists From Australia And New Zealand Discuss Stem Cell Research And Clinical Trials At 3rd Annual Conference In Cambridge, Massachusetts10/19/2005 5:11:29 PM
Feinstein Kean Healthcare Expands Creative Services To Meet Client Demand10/19/2005 5:11:16 PM
Janssen Pharmaceutica Products, L.P. Release: Risperdal Consta Improves Symptom Control In Many People With Schizophrenia10/19/2005 5:11:12 PM
Janssen Pharmaceutica Products, L.P. Release: Many Stabilized, Young Adults With Schizophrenia May Benefit From Early Treatment With Risperdal10/19/2005 5:11:12 PM
Feinstein Kean Healthcare, Inc.'s Rebranding Campaign For Nabi Biopharmaceuticals (NABI) Wins 2005 ReBrand 100(TM) Award10/19/2005 5:09:07 PM
Feinstein Kean Healthcare Release: New Office-Based Treatment For Prescription Drug And Heroin Addiction10/19/2005 5:08:57 PM